News

Hims & Hers Health, Inc. (HIMS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might

Howmet (HWM) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Advanced Micro Devices AMD reported first-quarter 2025 non-GAAP earnings of 96 cents per share, beating the Zacks Consensus Estimate by 3.23%. The figure surged 54.8% year over year. Revenues of

This summer, Delta Air Lines DAL plans to fly nonstop to Copenhagen and Stockholm, as well as to more than 35 destinations across Scandinavia, through its partnership with Scandinavian Airlines

Verisk VRSK has reported impressive first-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.

VRSK’s adjusted earnings were $1.73 per share, surpassing the Zacks

Rockwell Automation Inc. ROK has reported adjusted earnings per share (EPS) of $2.45 in second-quarter fiscal 2025 (ended March 31, 2025), surpassing the Zacks Consensus Estimate of $2.09. The

International Flavors & Fragrances Inc. IFF reported adjusted earnings of $1.20 per share in first-quarter 2025, beating the Zacks Consensus Estimate of $1.12. The bottom line improved 6% from the

Halozyme Therapeutics HALO reported first-quarter 2025 adjusted earnings of $1.11 per share, which comprehensively beat the Zacks Consensus Estimate of 95 cents. Earnings rose 41% year over year.

Sprouts Farmers Market SFM reported first-quarter 2025 results last Wednesday after the closing bell, fueling discussions among investors about the stock's future direction. The company, known for

Jack Henry & Associates JKHY reported third-quarter fiscal 2025 GAAP earnings of $1.52 per share, beating the Zacks Consensus Estimate by 17.83%. The figure jumped 27.7% year over year.Jack Henry &amp

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Five Below

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider BJ's Wholesale

Esperion Therapeutics ESPR incurred a loss of 21 cents per share in the first quarter of 2025, which was wider than the Zacks Consensus Estimate of a loss of 18 cents. In the year-ago quarter

Steven Madden, Ltd. SHOO reported first-quarter 2025 results, wherein the top line lagged the Zacks Consensus Estimate, while the bottom line surpassed the same. Total revenues increased and

Jones Lang LaSalle Incorporated JLL reported first-quarter 2025 adjusted earnings per share (EPS) of $2.31, which beat the Zacks Consensus Estimate of $2.02. The reported figure increased from the

Shares of Armanino Foods of Distinction, Inc. AMNF have gained 3.7% since reporting first-quarter 2025 results, outpacing the S&P 500’s 0.8% decline over the same period. However, on a broader

Voya Financial, Inc. VOYA reported first-quarter 2025 adjusted operating earnings of $2.15 per share, which beat the Zacks Consensus Estimate by 35.2%. The bottom line increased 14.4% year over

SkyWater Technology, Inc. (SKYT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Allient (ALNT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Bally's (BALY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces